125 related articles for article (PubMed ID: 16273102)
1. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
Veazey RS; Springer MS; Marx PA; Dufour J; Klasse PJ; Moore JP
Nat Med; 2005 Dec; 11(12):1293-4. PubMed ID: 16273102
[TBL] [Abstract][Full Text] [Related]
2. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
[TBL] [Abstract][Full Text] [Related]
3. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
4. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
[TBL] [Abstract][Full Text] [Related]
5. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.
Veazey RS; Klasse PJ; Ketas TJ; Reeves JD; Piatak M; Kunstman K; Kuhmann SE; Marx PA; Lifson JD; Dufour J; Mefford M; Pandrea I; Wolinsky SM; Doms RW; DeMartino JA; Siciliano SJ; Lyons K; Springer MS; Moore JP
J Exp Med; 2003 Nov; 198(10):1551-62. PubMed ID: 14623909
[TBL] [Abstract][Full Text] [Related]
6. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
Malcolm RK; Veazey RS; Geer L; Lowry D; Fetherston SM; Murphy DJ; Boyd P; Major I; Shattock RJ; Klasse PJ; Doyle LA; Rasmussen KK; Goldman L; Ketas TJ; Moore JP
Antimicrob Agents Chemother; 2012 May; 56(5):2251-8. PubMed ID: 22330914
[TBL] [Abstract][Full Text] [Related]
8. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.
García-Lerma JG; Cong ME; Mitchell J; Youngpairoj AS; Zheng Q; Masciotra S; Martin A; Kuklenyik Z; Holder A; Lipscomb J; Pau CP; Barr JR; Hanson DL; Otten R; Paxton L; Folks TM; Heneine W
Sci Transl Med; 2010 Jan; 2(14):14ra4. PubMed ID: 20371467
[TBL] [Abstract][Full Text] [Related]
9. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
10. Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors.
Dobard C; Sharma S; Parikh UM; West R; Taylor A; Martin A; Pau CP; Hanson DL; Lipscomb J; Smith J; Novembre F; Hazuda D; Garcia-Lerma JG; Heneine W
Sci Transl Med; 2014 Mar; 6(227):227ra35. PubMed ID: 24622515
[TBL] [Abstract][Full Text] [Related]
11. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission.
Poonia B; Wang X; Veazey RS
J Reprod Immunol; 2006 Dec; 72(1-2):74-84. PubMed ID: 16956666
[TBL] [Abstract][Full Text] [Related]
12. Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Bourry O; Brochard P; Souquiere S; Makuwa M; Calvo J; Dereudre-Bosquet N; Martinon F; Benech H; Kazanji M; Le Grand R
AIDS; 2009 Feb; 23(4):447-54. PubMed ID: 19240457
[TBL] [Abstract][Full Text] [Related]
13. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
[TBL] [Abstract][Full Text] [Related]
14. Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques.
Ferrantelli F; Buckley KA; Rasmussen RA; Chalmers A; Wang T; Li PL; Williams AL; Hofmann-Lehmann R; Montefiori DC; Cavacini LA; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM
Virology; 2007 Feb; 358(1):69-78. PubMed ID: 16996554
[TBL] [Abstract][Full Text] [Related]
15. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
[TBL] [Abstract][Full Text] [Related]
17. Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
Otten RA; Adams DR; Kim CN; Jackson E; Pullium JK; Lee K; Grohskopf LA; Monsour M; Butera S; Folks TM
J Infect Dis; 2005 Jan; 191(2):164-73. PubMed ID: 15609225
[TBL] [Abstract][Full Text] [Related]
18. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.
Veazey RS; Shattock RJ; Pope M; Kirijan JC; Jones J; Hu Q; Ketas T; Marx PA; Klasse PJ; Burton DR; Moore JP
Nat Med; 2003 Mar; 9(3):343-6. PubMed ID: 12579198
[TBL] [Abstract][Full Text] [Related]
19. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
[TBL] [Abstract][Full Text] [Related]
20. Medicine. Microbicide shuts the door on HIV.
Cohen J
Science; 2004 Oct; 306(5695):387. PubMed ID: 15486260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
